Eventide Asset Management’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,440,145
| Closed | -$15.1M | – | 139 |
|
|
2022
Q1 | $15.1M | Hold |
1,440,145
| – | – | 0.24% | 98 |
|
|
2021
Q4 | $21.7M | Hold |
1,440,145
| – | – | 0.28% | 93 |
|
|
2021
Q3 | $31.7M | Hold |
1,440,145
| – | – | 0.42% | 75 |
|
|
2021
Q2 | $36.2M | Buy |
1,440,145
+227,590
| +19% | +$5.71M | 0.49% | 63 |
|
|
2021
Q1 | $49M | Buy |
+1,212,555
| New | +$49M | 0.73% | 50 |
|